Steven Cohen Gilead Sciences, Inc. Transaction History
Point72 Asset Management, L.P.
- $44.6 Billion
- Q2 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 164,728 shares of GILD stock, worth $18.6 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
164,728
Previous 510,736
67.75%
Holding current value
$18.6 Million
Previous $57.2 Million
68.09%
% of portfolio
0.04%
Previous 0.14%
Shares
24 transactions
Others Institutions Holding GILD
# of Institutions
2,330Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.67 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.22 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.23 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $141B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...